Back to Results
First PageMeta Content
Food and Drug Administration / Clinical research / Treatment of bipolar disorder / Neurotechnology / Electroconvulsive therapy / Premarket approval / Medical device / Major depressive disorder / Federal Food / Drug / and Cosmetic Act / Medicine / Health / Psychiatry


FDA Executive Summary Prepared for the
Add to Reading List

Open Document

File Size: 619,08 KB

Share Result on Facebook
UPDATE